FGFR3–TACC3: A novel gene fusion in cervical cancer

Cervical cancer epitomizes the success of cancer prevention through the human papillomavirus (HPV) vaccine, but significant challenges remain in the treatment of advanced disease. We report the first three cases of cervical carcinoma harboring an FGFR3–TACC3 fusion, which serves as a novel therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Carneiro, Benedito A., Elvin, Julia A., Kamath, Suneel D., Ali, Siraj M., Paintal, Ajit S., Restrepo, Alvaro, Berry, Emily, Giles, Francis J., Johnson, Melissa L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563584/
https://www.ncbi.nlm.nih.gov/pubmed/26425723
http://dx.doi.org/10.1016/j.gore.2015.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563584/
https://www.ncbi.nlm.nih.gov/pubmed/26425723
http://dx.doi.org/10.1016/j.gore.2015.06.005

Ejemplares similares